Status:
COMPLETED
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Conditions:
Cancer
Leukemia
Eligibility:
All Genders
6-20 years
Brief Summary
The purpose of this study is to determine if C-Reactive Protein levels are predictive for complications post transplant.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 6 months to 20 years
- Patient undergoing a stem cell transplant (allogeneic, syngeneic, or autologous) at Childrens' Memorial Hospital
- IRB approved informed consent (and assent for children age 12-17)
Exclusion
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00179868
Start Date
January 1 2003
End Date
February 1 2008
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Memorial Hospital
Chicago, Illinois, United States, 60614